{"version":"1.0","type":"link","title":"Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in -Mutant Medullary Thyroid Cancer.","author_name":"Elisei R 외","author_url":"https://prs-insight.online/author/Elisei%20R","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/140245","thumbnail_width":1200,"thumbnail_height":630}